Development of novel vaccines using DNA shuffling and screening strategies

Current Opinion in Molecular Therapeutics

Volumn 6, Issue 1, 2004, Pages 34-39

  Locher, Christopher P ^a   Soong, Nay Wei ^a   Whalen, Robert G ^a   Punnonen, Juha ^b  

^a MAXYGEN INC   (United States)

^b Division of Immunotherapeutics   (United States)

Author keywords

Alphavirus; Dengue; Hepatitis; HIV; Malaria; Protein evolution

Indexed keywords

DNA; DNA VACCINE; HYBRID PROTEIN; VIRUS VACCINE;

ANIMAL; BIOLOGY; DIRECTED MOLECULAR EVOLUTION; DNA SHUFFLING; GENE THERAPY; GENETIC ENGINEERING; GENETIC RECOMBINATION; GENETICS; HUMAN; IMMUNOLOGY; MASS SCREENING; METHODOLOGY; REVIEW; VIRUS;

ANIMALS; COMPUTATIONAL BIOLOGY; DIRECTED MOLECULAR EVOLUTION; DNA; DNA SHUFFLING; GENE THERAPY; GENETIC ENGINEERING; HUMANS; MASS SCREENING; RECOMBINANT FUSION PROTEINS; RECOMBINATION, GENETIC; VACCINES, DNA; VIRAL VACCINES; VIRUSES;

EID: 3843148510     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Stemmer WP, Holland B: Survival of the fittest molecule. Am Sci (2003) 91(6):526-533.
2. Crameri A, Raillard SA, Bermudez E, Stemmer WP: DNA shuffling of a family of genes from diverse species accelerates directed evolution. Nature (1998) 391(6664):288-291.
3. Ness JE, Kim S, Gottman A, Pak R, Krebber A, Borchert TV, Govindarajan S, Mundorff EC, Minshull J: Synthetic shuffling expands functional protein diversity by allowing amino acids to recombine independently. Nat Biotechnol (2002) 20(12):1251-1255.
4. Patten PA, Howard RJ, Stemmer WP: Applications of DNA shuffling to pharmaceuticals and vaccines. Curr Opin Biotechnol (1997) 8(6):724-733.
5. Whalen RG, Kaiwar R, Soong NW, Punnonen J: DNA shuffling and vaccines. Curr Opin Mol Ther (2001) 3(1):31-36.
6. Tobin MB, Gustafsson C, Huisman GW: Directed evolution: The 'rational' basis for 'irrational' design. Curr Opin Struct Biol (2000) 10(4):421-427.
7. Stemmer WP: DNA shuffling by random fragmentation and reassembly: In vitro recombination for molecular evolution. Proc Natl Acad Sci USA (1994) 91(22):10747-10751.
8. Stemmer WP: Rapid evolution of a protein in vitro by DNA shuffling. Nature (1994) 370(6488):389-391.
9. Minshull J, Stemmer WP: Protein evolution by molecular breeding. Curr Opin Chem Biol (1999) 3(3):284-290.
10. Zhang JH, Dawes G, Stemmer WP: Directed evolution of a fucosidase from a galactosidase by DNA shuffling and screening. Proc Natl Acad Sci USA (1997) 94(9):4504-4509.
11. Chang CC, Chen TT, Cox BW, Dawes GN, Stemmer WP, Punnonen J, Patten PA: Evolution of a cytokine using DNA family shuffling. Nat Biotechnol (1999) 17(8):793-797.
12. Fox R, Roy A, Govindarajan S, Minshull J, Gustafsson C, Jones JT, Emig R: Optimizing the search algorithm for protein engineering by directed evolution. Protein Eng (2003) 16(8):589-597.
13. Moore GL, Maranas CD, Lutz S, Benkovic SJ: Predicting crossover generation in DNA shuffling. Proc Natl Acad Sci USA (2001) 98(6):3226-3231.
14. Maheshri N, Schaffer DV: Computational and experimental analysis of DNA shuffling. Proc Natl Acad Sci USA (2003) 100(6):3071-3076.
15. Lutz S, Ostermeier M, Moore GL, Maranas CD, Benkovic SJ: Creating multiple-crossover DNA libraries independent of sequence identity. Proc Natl Acad Sci USA (2001) 98(20):11248-11253.
16. Kurtzman AL, Govindarajan S, Vahle K, Jones JT, Heinrichs V, Patten PA: Advances in directed protein evolution by recursive genetic recombination: Applications to therapeutic proteins. Curr Opin Biotechnol (2001) 12(4):361-370.
17. Gibbs MD, Nevalainen KM, Bergquist PL: Degenerate oligonucleotide gene shuffling (DOGS): A method for enhancing the frequency of recombination with family shuffling. Gene (2001) 271(1):13-20.
18. Abecassis V, Jaffrelo L, Rickman D, Aggerbeck L, Herbert C, Truan G, Pompon D: Microarray-based method for combinatorial library sequence mapping and characterization. Biotechniques (2003) 34(6):1272-1279.
19. Joern JM, Meinhold P, Arnold FH: Analysis of shuffled gene libraries. J Mol Biol (2002) 316(3):643-656.
20. Jermutus L, Honegger A, Schwesinger F, Hanes J, Pluckthun A: Tailoring in vitro evolution for protein affinity or stability. Proc Natl Acad Sci USA (2001) 98(1):75-80.
21. Borst P: Antigenic variation and allelic exclusion. Cell (2002) 109(1):5-8.
22. Young D, Hussell T, Dougan G: Chronic bacterial infections: Living with unwanted guests. Nat Immunol (2002) 3(11):1026-1032.
23. Barbour AG, Restrepo BI: Antigenic variation in vector-borne pathogens. Emerg Infect Dis (2000) 6(5):449-457.
24. Capiau C, Poolman J, Hoet B, Bogaerts H, Andre F: Development and clinical testing of multivalent vaccines based on a diphtheria-tetanus-acellular pertussis vaccine: Difficulties encountered and lessons learned. Vaccine (2003) 21(19-20):2273-2287.
25. Billich A: HPV vaccine MedImmune/GlaxoSmithKline. Curr Opin Investig Drugs (2003) 4(2):210-213.
26. Obaro SK: The new pneumococcal vaccine. Clin Microbiol Infect (2002) 8(10):623-633.
27. Baruch DI, Pasloske BL, Singh HB, Bi X, Ma XC, Feldman M, Taraschi TF, Howard RJ: Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes. Cell (1995) 82(1):77-87.
28. Bull PC, Lowe BS, Kortok M, Molyneux CS, Newbold CI, Marsh K: Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria. Nat Med (1998) 4(3):358-360.
29. Baruch DI, Gamain B, Barnwell JW, Sullivan JS, Stowers A, Galland GG, Miller LH, Collins WE: Immunization of Aotus monkeys with a functional domain of the Plasmodium falciparum variant antigen induces protection against a lethal parasite line. Proc Natl Acad Sci USA (2002) 99(6):3860-3865.
30. Sin JI, Kim J, Chattergoon M, Ayyavoo V, McCallus D, Ugen KE, Boyer JD, Weiner DB: Engineering of DNA vaccines using molecular adjuvant plasmids. Dev Biol (2000) 104:187-198.
31. Tsuji T, Hamajima K, Ishii N, Aoki I, Fukushima J, Xin KQ, Kawamoto S, Sasaki S, Matsunaga K, Ishigatsubo Y, Tani K et al: Immunomodulatory effects of a plasmid expressing B7-2 on human immunodeficiency virus-1-specific cell-mediated immunity induced by a plasmid encoding the viral antigen. Eur J Immunol (1997) 27(3):782-787.
32. Agadjanyan MG, Kim JJ, Trivedi N, Wilson DM, Monzavi-Karbassi B, Morrison LD, Nottingham LK, Dentchev T, Tsai A, Dang K, Chalian AA et al: CD86 (B7-2) can function to drive MHC-restricted antigen-specific CTL responses in vivo. J Immunol (1999) 162(6):3417-3427.
33. Lazetic S, Leong SR, Chang JC, Ong R, Dawes G, Punnonen J: Chimeric co-stimulatory molecules that selectively act through CD28 or CTLA-4 on human T cells. J Biol Chem (2002) 277(41):38660-38668.
34. Trinchieri G, Scott P: Interleukin-12: Basic principles and clinical applications. Curr Top Microbiol Immunol (1999) 238:57-78.
35. Leong SR, Chang JC, Ong R, Dawes G, Stemmer WP, Punnonen J: Optimized expression and specific activity of IL-12 by directed molecular evolution. Proc Natl Acad Sci USA (2003) 100(3):1163-1168.
36. Pekrun K, Shibata R, Igarashi T, Reed M, Sheppard L, Patten PA, Stemmer WP, Martin MA, Soong NW: Evolution of a human immunodeficiency virus type 1 variant with enhanced replication in pig-tailed macaque cells by DNA shuffling. J Virol (2002) 76(6):2924-2935.
37. Powell SK, Kaloss MA, Pinkstaff A, McKee R, Burimski I, Pensiero M, Otto E, Stemmer WP, Soong NW: Breeding of retroviruses by DNA shuffling for improved stability and processing yields. Nat Biotechnol (2000) 18(12):1279-1282.
38. Zhang YX, Perry K, Vinci VA, Powell K, Stemmer WP, del Cardayre SB: Genome shuffling leads to rapid phenotypic improvement in bacteria. Nature (2002) 415(6872):644-646.